Impact of body mass index on neoadjuvant treatment outcome: a pooled analysis of eight prospective neoadjuvant breast cancer trials
Obesity is associated with an increased risk of breast cancer (BC) and poorer outcome. We assessed the impact of body mass index (BMI) on pathological complete response (pCR), disease-free (DFS), and overall survival (OS), according to BC subtypes in patients with primary BC treated with neoadjuvant...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
13 February 2015
|
| In: |
Breast cancer research and treatment
Year: 2015, Volume: 150, Issue: 1, Pages: 127-139 |
| ISSN: | 1573-7217 |
| DOI: | 10.1007/s10549-015-3287-5 |
| Online Access: | Verlag, Volltext: http://dx.doi.org/10.1007/s10549-015-3287-5 Verlag, Volltext: https://link.springer.com/article/10.1007/s10549-015-3287-5 Verlag, Abstract, Volltext: http://link.springer.com/article/10.1007/s10549-015-3287-5 |
| Author Notes: | Caterina Fontanella, Bianca Lederer, Stephan Gade, Mieke Vanoppen, Jens Uwe Blohmer, Serban Dan Costa, Carsten Denkert, Holger Eidtmann, Bernd Gerber, Claus Hanusch, Jörn Hilfrich, Jens Huober, Andreas Schneeweiss, Stefan Paepke, Christian Jackisch, Keyur Mehta, Valentina Nekljudova, Michael Untch, Patrick Neven, Gunter von Minckwitz, Sibylle Loibl |